These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
888 related articles for article (PubMed ID: 33283409)
1. The epidermal growth factor receptor variant type III mutation frequently found in gliomas induces astrogenesis in human cerebral organoids. Kim HM; Lee SH; Lim J; Yoo J; Hwang DY Cell Prolif; 2021 Feb; 54(2):e12965. PubMed ID: 33283409 [TBL] [Abstract][Full Text] [Related]
2. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Feldkamp MM; Lala P; Lau N; Roncari L; Guha A Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712 [TBL] [Abstract][Full Text] [Related]
3. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502 [TBL] [Abstract][Full Text] [Related]
4. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status. Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314 [TBL] [Abstract][Full Text] [Related]
5. EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. Mukherjee B; McEllin B; Camacho CV; Tomimatsu N; Sirasanagandala S; Nannepaga S; Hatanpaa KJ; Mickey B; Madden C; Maher E; Boothman DA; Furnari F; Cavenee WK; Bachoo RM; Burma S Cancer Res; 2009 May; 69(10):4252-9. PubMed ID: 19435898 [TBL] [Abstract][Full Text] [Related]
12. Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR. Vaidya KS; Mitten MJ; Zelaya-Lazo AL; Oleksijew A; Alvey C; Falls HD; Mishra S; Palma J; Ansell P; Phillips AC; Reilly EB; Anderson M; Boghaert ER J Neurooncol; 2021 Apr; 152(2):233-243. PubMed ID: 33517558 [TBL] [Abstract][Full Text] [Related]
13. Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion. Gilder AS; Jones KA; Hu J; Wang L; Chen CC; Carter BS; Gonias SL J Biol Chem; 2015 Jun; 290(24):14798-809. PubMed ID: 25837250 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts. Johnson H; Del Rosario AM; Bryson BD; Schroeder MA; Sarkaria JN; White FM Mol Cell Proteomics; 2012 Dec; 11(12):1724-40. PubMed ID: 22964225 [TBL] [Abstract][Full Text] [Related]
15. Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature. Jones KA; Gilder AS; Lam MS; Du N; Banki MA; Merati A; Pizzo DP; VandenBerg SR; Gonias SL Neuro Oncol; 2016 May; 18(5):667-78. PubMed ID: 26420897 [TBL] [Abstract][Full Text] [Related]
16. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells. Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476 [TBL] [Abstract][Full Text] [Related]
17. The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells. Estrada-Bernal A; Lawler SE; Nowicki MO; Ray Chaudhury A; Van Brocklyn JR J Neurooncol; 2011 May; 102(3):353-66. PubMed ID: 20938717 [TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma. Katanasaka Y; Kodera Y; Kitamura Y; Morimoto T; Tamura T; Koizumi F Mol Cancer; 2013 Apr; 12():31. PubMed ID: 23617883 [TBL] [Abstract][Full Text] [Related]
19. FHL2 interacts with EGFR to promote glioblastoma growth. Sun L; Yu S; Xu H; Zheng Y; Lin J; Wu M; Wang J; Wang A; Lan Q; Furnari F; Cavenee W; Purow B; Li M Oncogene; 2018 Mar; 37(10):1386-1398. PubMed ID: 29321665 [TBL] [Abstract][Full Text] [Related]
20. Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth. Hu L; Shen D; Liang D; Shi J; Song C; Jiang K; Menglin Ren ; Du S; Cheng W; Ma J; Li S; Bi X; Barr MP; Fang Z; Xu Q; Li W; Piao H; Meng S Cancer Lett; 2020 Nov; 493():156-166. PubMed ID: 32860853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]